KARD

Kardigan, Inc.
CAPPED RATING

Kardigan, Inc. (KARD) is rated C- (2.1/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (C+); its weakest is Profitability (D-). The rating has held at C- for 3 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.1 / 5.0
C-
Value
C+
Factor Score 2.5 / 5.0
Growth
C+
Factor Score 2.7 / 5.0
Profitability
D-
Factor Score 0.8 / 5.0
Momentum
D+
Factor Score 1.6 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -3.8
EV / EBITDA -3.3
Rev Growth YoY N/A
Gross Margin 0.0%
Price Return 3M -28.1%
Price Return 12M -28.7%
Catalyst Signal 0.00
Market Cap $1.5B
TTM Revenue N/A
Price / Sales N/A
ROE N/A

Historical Factor Score Progression

Held C- for 3 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-12 C+ (2.5) C+ (2.7) D- (0.8) D+ (1.6) C+ (2.6) C- (2.1)
2026-11-05 C+ (2.5) C+ (2.6) D- (0.8) D+ (1.7) C+ (2.7) C- (2.1)
2026-10-29 C+ (2.5) C+ (2.6) D- (0.8) D+ (1.5) C+ (2.7) C- (2.0)
2026-10-22 C+ (2.5) C+ (2.6) D- (0.8) D+ (1.5) C+ (2.6) C- (2.0)
2026-10-15 C+ (2.5) B (3.2) D- (0.8) D+ (1.8) C+ (2.6) C (2.2)
Page 1 of 4